α-lipoic acid reduces congenital malformations in the offspring of diabetic mice

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 3, 2009, Pages 287-294

  Sugimura, Y ^a,b   Murase, T ^a   Kobayashi, K ^a   Oyama, K ^a   Hayasaka, S ^a   Kanou, Y ^a   Oiso, Y ^b   Murata, Y ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

lipoic acid; Cardiovascular malformations; Diabetic pregnancy; Neural tube defects; Oxidative stress; Skeletal malformations

Indexed keywords

GLUCOSE; GLUTATHIONE SYNTHASE; THIOCTIC ACID; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; CROWN RUMP LENGTH; EXENCEPHALY; FEMALE; FETUS MALFORMATION; FETUS WEIGHT; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HYPERGLYCEMIA; INCIDENCE; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; SKELETON MALFORMATION; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; CONGENITAL DISORDER; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FETUS RESORPTION; LITTER SIZE; LIVER; METABOLISM; PREGNANCY;

ANIMALS; BLOOD GLUCOSE; CARDIOVASCULAR ABNORMALITIES; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FETAL RESORPTION; GLUTATHIONE; LITTER SIZE; LIVER; MALE; MICE; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY IN DIABETICS; THIOCTIC ACID;

EID: 65649150376     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.947     Document Type: Article

References (50)

1. Mills JL. Malformations in infants of diabetic mothers. Teratology 1982; 25l: 385-394.
2. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990; 85l: 1-9.
3. Kousseff BG. Diabetic embryopathy. Curr Opin Pediatr 1999; 11l: 348-352.
4. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 1971; 7l: 73-82.
5. Hawthorne G, Robson S, Ryall EA, Sen D, Roberts SH, Ward Platt MP. Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994. BMJ 1997; 315l: 279-281.
6. Casson IF, Clarke CA, Howard CV, et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 1997; 315l: 275-278.
7. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004; 328l: 915.
8. Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000; 43l: 79-82.
9. Trocino RA, Akazawa S, Ishibashi M, et al. Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 1995; 44l: 992-998.
10. Yang X, Borg LA, Eriksson UJ. Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 1997; 272l: E173-E180.
11. Eriksson UJ, Borg LA. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia 1991; 34l: 325-331.
12. Sivan E, Lee YC, Wu YK, Reece EA. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats. Teratology 1997; 56l: 343-349.
13. Sivan E, Reece EA, Wu YK, Homko CJ, Polansky M, Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy: morphologic and biochemical analysis. Am J Obstet Gynecol 1996; 175l: 793-799.
14. Siman CM, Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997; 46l: 1054-1061.
15. Siman CM, Eriksson UJ. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 1997; 40l: 1416-1424.
16. Wentzel P, Thunberg L, Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture. Diabetologia 1997; 40l: 7-14.
17. Sakamaki H, Akazawa S, Ishibashi M, et al. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 1999; 48l: 1138-1144.
18. Eriksson UJ, Siman CM. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring. Diabetes 1996; 45l: 1497-1502.
19. Hagay ZJ, Weiss Y, Zusman I, et al. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 1995; 173l: 1036-1041.
20. Machado AF, Zimmerman EF, Hovland DN Jr, Weiss R, Collins MD. Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele. Diabetes 2001; 50l: 1193-1199.
21. Siman CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 2000; 61l: 355-367.
22. Molin DG, Roest PA, Nordstrand H, et al. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res A Clin Mol Teratol 2004; 70l: 927-938.
23. Roest PA, van Iperen L, Vis S, et al. Exposure of neural crest cells to elevated glucose leads to congenital heart defects, an effect that can be prevented by N-acetylcysteine. Birth Defects Res A Clin Mol Teratol 2007; 79l: 231-235.
24. Morgan SC, Relaix F, Sandell LL, Loeken MR. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res A Clin Mol Teratol 2008; 82l: 453-463.
25. Packer L, Weber SU, Rimbach G. Molecular aspects of alphatocotrienol antioxidant action and cell signalling. J Nutr 2001; 131l: 369S-373S.
26. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22l: 1296-1301.
27. Nagamatsu M, Nickander KK, Schmelzer JD, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18l: 1160-1167.
28. Melhem MF, Craven PA, Derubertis FR. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 2001; 12l: 124-133.
29. Wiznitzer A, Ayalon N, Hershkovitz R, et al. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol 1999; 180l: 188-193.
30. Al Ghafli MH, Padmanabhan R, Kataya HH, Berg B. Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses. Mol Cell Biochem 2004; 261l: 123-135.
31. Torchinsky A, Toder V, Savion S, Shepshelovich J, Orenstein H, Fein A. Immunostimulation increases the resistance of mouse embryos to the teratogenic effect of diabetes mellitus. Diabetologia 1997; 40l: 635-640.
32. Kishi Y, Schmelzer JD, Yao JK, et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 1999; 48l: 2045-2051.
33. Eriksson U, Dahlstrom E, Larsson KS, Hellerstrom C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 1982; 31l: 1-6.
34. Wilson JG. Methods of administering agents and detecting malformations in experimental animals. In Teratology: Principles and Techniques, Wilson JG, Warkany J (eds). The University of Chicago Press: Chicago, 1965.
35. Nishimura K. A microdissection methods for detecting thoracic visceral malformations in mouse and rat fetuses. Congenit Anom (Kyoto) 1974; 14l: 23-40.
36. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Congenit Anom (Kyoto) 1976; 16l: 171-173.
37. Cederberg J, Siman CM, Eriksson UJ. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 2001; 49l: 755-762.
38. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30l: 1191-1212.
39. Horal M, Zhang Z, Stanton R, Virkamaki A, Loeken MR. Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesis. Birth Defects Res A Clin Mol Teratol 2004; 70l: 519-527.
40. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. J Soc Gynecol Investig 2006; 13l: 2-10.
41. Wentzel P, Welsh N, Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999; 48l: 813-820.
42. Sadler TW, Phillips LS, Balkan W, Goldstein S. Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture. Diabetes 1986; 35l: 861-865.
43. Hashimoto M, Akazawa S, Akazawa M, et al. Effects of hyperglycaemia on sorbitol and myo-inositol contents of cultured embryos: treatment with aldose reductase inhibitor and myo-inositol supplementation. Diabetologia 1990; 33l: 597-602.
44. Goto MP, Goldman AS, Uhing MR. PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos. Diabetes 1992; 41l: 1644-1650.
45. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 1997; 46l: 1189-1197.
46. Kirby ML, Stewart DE. Neural crest origin of cardiac ganglion cells in the chick embryo: identification and extirpation. Dev Biol 1983; 97l: 433-443.
47. Conway SJ, Henderson DJ, Copp AJ. Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2H) mutant. Development 1997; 124l: 505-514.
48. Pani L, Horal M, Loeken MR. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002; 16l: 676-680.
49. Chang TI, Horal M, Jain SK, Wang F, Patel R, Loeken MR. Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003; 46l: 538-545.
50. Kumar SD, Dheen ST, Tay SS. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc Diabetol 2007; 6l: 34.